skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi. I'm curious about your thoughts on big tobacco becoming big pharma as far as medical cannabis goes. I am surprised that they haven't yet entered this space. Do you think this will eventually happen? With the big drop on tobacco stocks today I'm wondering if I should start a position.
Read Answer Asked by Edward on July 31, 2017
Q: The above group of companies, so called bond proxies medical supply and consumer staples do not seem to be participating in the Trump boost post election. Many have sold off sharply. Do you view this as a buying opportunity?
Read Answer Asked by Andrew on November 29, 2016
Q: Which company would be your top pick in the medical devices space in Canada? Prism seems to cover all the bases for seniors wishing to remain in their homes throughout retirement and retrofitting their homes accordingly, but it is small (listed on the Venture Exchange). However, it does pay a nice dividend. Any thoughts?
Read Answer Asked by Paul W on April 11, 2016
Q: Any thoughts on PM's quarterly numbers? There seems to be an enormous chasm between the expected earnings per share and what Prism actually delivered. Taking into account the one time items, the gap closes a little but still I'd like your expert opinion on the numbers.

Revenues were up nicely but earnings fell significantly. Do you see anything in the numbers that raises a red flag or cause for concern?

2016 earnings per share estimates were 75 cents, prior to today's q3 numbers. Any guesses what the new estimates will be for 2016?

Thanks for your time.

John
Read Answer Asked by john on October 28, 2015
Q: I wonder if the sum of your report card categories for PM reflect your overall opinion of the company. Your report has 12 categories and PM received 83% of A, 33 % of B and 17% C. Yet, It's overall rating is C+. Does this suggest that some categories should be weighted or do you need more categories or maybe C+ is too severe? ...Sleepless in Niagara
Read Answer Asked by Danny-boy on July 03, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!